Evidence map›Paper›PMID 37193437›Full record

ArticleCureus2023

A Once-Thought Lipoma Turned Malignant Chondroid Syringoma.

Noelle Provenzano, Emerson T Trimble, Kenneth Zeitzer, Christopher Williamson, Mitchell Goldstein

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Noelle ProvenzanoInternal Medicine, Einstein Medical Center Montgomery, East Norriton, USA.
Emerson T TrimbleFamily Medicine, Touro College of Osteopathic Medicine, New York, USA.
Kenneth ZeitzerRadiation Oncology, Einstein Medical Center Montgomery, East Norriton, USA.
Christopher WilliamsonOrthopedic Surgery, Einstein Medical Center Montgomery, East Norriton, USA.
Mitchell GoldsteinHematology and Medical Oncology, Einstein Medical Center Montgomery, East Norriton, USA.
Touro College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chondroid syringoma is a relatively rare benign skin appendageal tumor with an incidence of <0.098%. Malignant chondroid syringoma (MCS) arises from cutaneous sweat glands and occurs on the extremities or trunk more commonly in women with only 51 reported cases. Due to the rarity of the disease and lack of published cases of MCS, the diagnostic criteria and treatment protocols are not clear. Based on available recommendations and histological criteria, MCS was diagnosed in a previously classified elbow lipoma following increased size and pain, and skin color changes in a 65-year-old woman.

Indexed as

chondroid syringomalipomamalignant chondroid syringomarisk of malignancyskin tumor

Identifiers

PMID37193437
PMCPMC10182779
OpenAlexW4365446965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.